title: Influence of smoking history on breast cancer prognosis: retrospective study of 240 operable breast cancer patients who received adjuvant cyclophosphamide, doxorubicin, and 5-fluorouracil chemotherapy regimen.
authors.forename: Sercan
authors.initials: S
authors.lastname: Aksoy
authors.forename: Hakan
authors.initials: H
authors.lastname: Harputluoglu
authors.forename: Nilufer
authors.initials: N
authors.lastname: Guler
authors.forename: Kadri
authors.initials: K
authors.lastname: Altundag
authors.forename: Mutlu
authors.initials: M
authors.lastname: Hayran
authors.forename: Gulten
authors.initials: G
authors.lastname: Tekuzman
authors.forename: Yavuz
authors.initials: Y
authors.lastname: Ozisik
mesh_terms: D000328:Adult; D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage; D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage; D018906:Antineoplastic Agents, Alkylating / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy*; D017024:Chemotherapy, Adjuvant; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D008499:Medical Records; D008875:Middle Aged; D011379:Prognosis; D012189:Retrospective Studies; D012907:Smoking
chemical_list: D000903:Antibiotics, Antineoplastic; D000964:Antimetabolites, Antineoplastic; D018906:Antineoplastic Agents, Alkylating; D004317:Doxorubicin; D003520:Cyclophosphamide; D005472:Fluorouracil